Aktie A0BLXB MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Medical Developments International Limited

Aktien

A0BLXB

AU000000MVP2

MVP

Markt geschlossen - Australian S.E.
Andere Börsenplätze
 08:10:55 23.04.2024 		% 5 Tage % 1. Jan.
0,55 AUD +0,92 % Intraday Chart für Medical Developments International Limited -4,35 % -27,63 %
29.02. Transcript : Medical Developments International Limited, H1 2024 Earnings Call, Feb 29, 2024
28.02. Medical Developments International Limited berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Halbjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Medical Developments International Limited Reports Earnings Results for the Half Year Ended December 31, 2023
Medical Developments International Limited(ASX:MVP) dropped from S&P/ASX Emerging Companies Index
Medical Developments International Limited Appoints Russell Basser to the Board Effective 1 September 2023
Medical Developments International Limited Reports Earnings Results for the Full Year Ended June 30, 2023
Medical Developments International Limited Announces Resignation of David Williams from Board
Medical Developments International Searches for Partner to Commercialize Pain Relief Product in the US
Medical Developments International Limited(ASX:MVP) dropped from S&P/ASX All Ordinaries Index
Medical Developments International Limited Reports Earnings Results for the Half Year Ended December 31, 2022
Medical Developments Stops Clinical Trial Preparation for Penthrox in China; Shares Rise 6%
Medical Developments International Limited Discontinues China Clinical Trials
Medical Developments International Limited Provides Revenue Guidance for the Year 2023
Medical Developments International Limited Announces Resignation of Max Johnston as Director, Effective 27 October 2022
Medical Developments International Limited(ASX:MVP) dropped from S&P Global BMI Index
Medical Developments International Limited Reports Earnings Results for the Full Year Ended June 30, 2022
Medical Developments International Limited Reports Earnings Results for the Full Year Ended June 30, 2022
Medical Developments International Sees Negative FY22 EBITDA, Launches Capital Hike
Medical Developments International Limited Provides Earnings Guidance for the Fiscal Year 2022 and Revenue Guidance for the Fiscal Year 2023
Medical Developments International Limited Appoints Tara Eaton as General Counsel and Company Secretary, Effective August 8, 2022
Medical Developments International Signs New Penthrox Licensing Agreement in Canada with New Partner Endo Ventures Limited
Medical Developments International Limited Announces Chief Financial Changes
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A0BLXB Aktie
  4. Nachrichten Medical Developments International Limited
  5. Andere Sprachen